All Pharma News
Repare Provides Update, Q1 2024 Results

Repare Provides Update, Q1 2024 Results
BUSINESSWIRE
07 May 2024
Share Share
Repare, Debiopharm Dose First Patient In MYTHIC Combo Trial

Repare, Debiopharm Dose First Patient In MYTHIC Combo Trial
BUSINESSWIRE
30 Apr 2024
Share Share
Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
BUSINESSWIRE
26 Apr 2024
Share Share
Repare Therapeutics to Participate in Two Upcoming Investor Conferences

Repare Therapeutics to Participate in Two Upcoming Investor Conferences
PRESS RELEASE
29 Feb 2024
Share Share
Repare Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Repare Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
28 Feb 2024
Share Share
Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-1664

Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-1664
PRESS RELEASE
15 Feb 2024
Share Share
Roche walks away from Repare solid tumor deal

Roche walks away from Repare solid tumor deal
Ayisha Sharma ENDPTS
13 Feb 2024
Share Share
Repare Therapeutics to Regain Global Rights to Camonsertib

Repare Therapeutics to Regain Global Rights to Camonsertib
BUSINESSWIRE
12 Feb 2024
Share Share
Repare Announces Achievement of $40 Million Roche Clinical Milestone Payment

Repare Announces Achievement of $40 Million Roche Clinical Milestone Payment
BUSINESSWIRE
25 Jan 2024
Share Share
Repare Provides Corporate Update and Highlights Anticipated Key 2024 Milestones

Repare Provides Corporate Update and Highlights Anticipated Key 2024 Milestones
BUSINESSWIRE
08 Jan 2024
Share Share